Summary
May 2005, Vol. 6, No. 5, Pages 835-837 , DOI 10.1517/14656566.6.5.835

Sildenafil for the treatment of altitude-induced hypoxaemia
RICHALET J-P, GRATADOUR P, ROBACH P et al.: Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension. Am. J. Respir. Crit. Care. Med. (2005) 171:275-281 [1].

Petros Perimenis
Medical School
University of Patras, 26500 Rio, Patras
Greece
E-mail:



Exposure to high altitude causes alveolar hypoxia and induces pulmonary hypertension (PH) with consequent limitation of exercise capacity. To assess the impact of sildenafil on haemodynamic and clinical parameters, and on aerobic performance, 12 young healthy unacclimatised subjects were studied (6 received sildenafil 40 mg t.i.d. and 6 received placebo) at sea level and high altitude. Systolic pulmonary artery pressure increased at high altitude, but normalised with sildenafil. The altitude-induced decrease in maximal O2 consumption was significantly smaller with sildenafil than with placebo. Enhancing pulmonary circulation with sildenafil safely protects against the high altitude-induced PH and improves gas exchange.

PDF (52 KB) | PDF Plus (108 KB)

Forward Links to Citing Articles

Charalambos Vlachopoulos, Nikolaos Ioakeimidis, Konstantinos Rokkas, Christodoulos Stefanadis. (2009) Cardiovascular Effects of Phosphodiesterase Type 5 Inhibitors. Journal of Sexual Medicine 6:3, 658-674
Online publication date: 1-Apr-2009.
CrossRef
Taymour Mostafa. (2008) Oral Phosphodiesterase Type 5 Inhibitors: Nonerectogenic Beneficial Uses. Journal of Sexual Medicine 5:11, 2502-2518
Online publication date: 1-Dec-2008.
CrossRef
 

Prev. Article | Next Article
View/Print PDF (52 KB)
View PDF Plus (108 KB)
Add to favourite
Email to a friend
TOC Alert | Citation Alert What is RSS?

 
 
Quick Search
for 
Author:
Petros Perimenis
Keywords:
altitude-induced hypoxaemia
cardiac output
exercise
pulmonary hypertension
sildenafil